Cross-Talk in Nucleotide Signaling in Glioma C6 Cells

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Glioma C6 cells express various purinergic receptors, including metabotropic P2Y and ionotropic P2X receptors.
• P2Y1 and P2Y12 receptors both bind ADP but have distinct downstream signaling pathways.
• Cellular responses to purinergic signaling are influenced by physiological conditions like serum availability.

Purpose of the Study:

• To elucidate the mechanism of action of specific P2Y (P2Y1, P2Y2, P2Y12, P2Y14) and P2X7 receptors in glioma C6 cells.
• To investigate how serum deprivation affects nucleotide receptor expression and signaling in glioma cells.
• To understand the role of these receptors in regulating cell survival and invasiveness.

Main Methods:

• Analysis of P2Y1, P2Y12, and P2X7 receptor function in glioma C6 cells.
• Assessment of signaling pathways including PLC, Ca2+, adenylate cyclase, cAMP, ERK1/2, and PI3K/Akt.
• Evaluation of receptor expression and activity under conditions of serum deprivation.

Main Results:

• P2Y1 activation elevates cytosolic Ca2+ via PLC, while P2Y12 maintains low cAMP by inhibiting adenylate cyclase.
• During serum deprivation, P2Y1 expression decreases, and P2Y12 becomes dominant, activating ERK1/2 and Akt pathways.
• P2Y12 signaling promotes glioma invasiveness, whereas P2Y1 inhibits the Akt pathway; P2X7 is not involved in Ca2+ elevation.

Conclusions:

• A shift in nucleotide receptor expression from P2Y1 to P2Y12 during serum withdrawal is observed in glioma C6 cells.
• This receptor modulation, along with cross-talk and lack of P2X7 activity, constitutes a self-regulating mechanism for enhanced cell survival and preserved neoplastic features.
• P2Y12 signaling plays a critical role in promoting glioma cell invasiveness and survival under stress conditions.